This week, the Federal Trade Commission hit virtual mental health startup Cerebral with a $7 million fine, accusing the company of mishandling users’ sensitive health data and misleading consumers about cancellation policies.
Cerebral agreed to…
Continue Reading
What You Should Know:
– Cerebral, a company offering online mental health services, has agreed to pay over $7 million to settle Federal Trade Commission (FTC) charges.
– The FTC alleged that Cerebral failed to secure…
Continue Reading
What You Should Know:
– Whistleblower Aid, a non-profit organization supporting whistleblowers, is urging the Federal Trade Commission (FTC) to take action against 22 additional digital health providers following the recent FTC case against Monument…
Continue Reading
U.S. Health and Human Services Secretary Xavier Becerra has appointed Stacy Sanders as the agency’s first chief competition officer. In that role, she will lead efforts to implement healthcare-focused elements of the President’s 2021…
Continue Reading
Explore the nuances of healthcare pixel tracking and privacy concerns, revealing the interplay between pixels, health data, and compliance. Betsy Hodge, Akerman’s partner, advocates vigilance in aligning tracking practices with evolving privacy laws. Pixels,…
Continue Reading
The Department of Health and Human Services and the Federal Trade Commission sent letters to hospitals this summer warning them that using third-party analytics tools on their websites could violate HIPAA. But a new…
Continue Reading
Shareholders of healthcare-at-home specialist Amedisys voted in favor of the roughly $3.3 billion pending acquisition by Optum, a subsidiary of UnitedHealth Group, according to a Securities and Exchange Commission filing.The shareholders approved the adoption…
Continue Reading
By Jill McKeon
September 07, 2023 – In a document that spans hundreds of pages, HHS and the Federal Trade Commission (FTC) published letters sent to 130 healthcare organizations regarding the security and privacy risks of…
Continue Reading
The Federal Trade Commission has filed a proposed order settling charges that e-prescribing giant Surescripts used anticompetitive business practices to monopolize two e-prescription drug markets.
The order follows on the heels of a prior federal…
By Hannah Nelson
July 31, 2023 – Health IT vendor Surescripts has settled its case with the Federal Trade Commission (FTC) without monetary penalties.
The FTC filed an antitrust lawsuit against Surescripts in April 2019 for allegedly monopolizing…
